ORCID
- David Sheridan: 0000-0001-5100-814X
DOI Link
DOI
10.1016/s2468-1253(20)30357-5
Publication Date
2021-01-01
Publication Title
The Lancet Gastroenterology & Hepatology
Volume
6
Issue
3
ISSN
2468-1253
Embargo Period
2023-05-06
First Page
185
Last Page
198
Recommended Citation
Karlas, T., Petroff, D., Blank, V., Newsome, P., Shalimar., Voican, C., Thiele, M., de, L., Baumeler, S., Chan, W., Perlemuter, G., Cardoso, A., Aggarwal, S., Sasso, M., Eddowes, P., Allison, M., Tsochatzis, E., Anstee, Q., Sheridan, D., Cobbold, J., Naveau, S., Lupsor-Platon, M., Mueller, S., Krag, A., Irles-Depe, M., Semela, D., Wong, G., Wong, V., Villela-Nogueira, C., Garg, H., Wiegand, J., & Karlas, T. (2021) 'Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis', The Lancet Gastroenterology & Hepatology, 6(3), pp. 185-198. Available at: 10.1016/s2468-1253(20)30357-5
